BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34187411)

  • 21. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
    Zhao XD; Zhang W; Liang HJ; Ji WY
    PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.
    Luo HN; Wang ZH; Sheng Y; Zhang Q; Yan J; Hou J; Zhu K; Cheng Y; Xu YL; Zhang XH; Xu M; Ren XY
    Med Oncol; 2014 Jan; 31(1):789. PubMed ID: 24318902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.
    Zhao J; Li XD; Wang M; Song LN; Zhao MJ
    Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulating of cell cycle progression by the lncRNA CDKN2B-AS1/miR-324-5p/ROCK1 axis in laryngeal squamous cell cancer.
    Liu F; Xiao Y; Ma L; Wang J
    Int J Biol Markers; 2020 Mar; 35(1):47-56. PubMed ID: 31960744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.
    Lv Y; Ye D; Qiu S; Zhang J; Shen Z; Shen Y; Deng H
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
    Wan L; Gu D; Jin X
    Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.
    Yang S; Wang J; Ge W; Jiang Y
    J Cell Biochem; 2018 Aug; 119(8):6953-6960. PubMed ID: 29737563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
    Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paired Box 5-Induced LINC00467 Upregulation Promotes the Progression of Laryngeal Squamous Cell Cancer by Triggering the MicroRNA-4735-3p/TNF Alpha-Induced Protein 3 Pathway.
    Li Y; Wu Y; Dai L; Wu H; Chen C; Ni J; Jin E; Zhou X
    Mol Biotechnol; 2023 Apr; 65(4):655-667. PubMed ID: 36214976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA CASC15 upregulates cyclin D1 by downregulating miR-365 in laryngeal squamous cell carcinoma to promote cell proliferation.
    Zhu M; Zhang C; Zhou P; Chen S; Zheng H
    J Otolaryngol Head Neck Surg; 2022 Feb; 51(1):8. PubMed ID: 35216636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
    Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
    Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
    Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
    Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
    Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
    Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of circMYOF inhibits cell growth, metastasis, and glycolysis through miR-145-5p/OTX1 regulatory axis in laryngeal squamous cell carcinoma.
    Li S; Zhang Y; He Z; Xu Q; Li C; Xu B
    Funct Integr Genomics; 2022 Aug; 22(4):1-13. PubMed ID: 35474406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.